Skip to content

Postural bowleg and hip joint exercise

A one-group clinical study for evaluation of efficacy and safety by YESLEG as a non-operative treatment in bowleg patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0001972
Enrollment
50
Registered
2016-07-18
Start date
2010-01-04
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Applicants visit the hospital and perform YESLEG®(BCS-800) exercise, which is composed of 5 sessions of 30-minute exercise each week for 3 months.

Sponsors

Hallym University Medical Center-Kangnam
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Female patient whose age is between 18 and 50, who is not pregnant nor planning for pregnancy in 3 months. 2. Female patient who has O-shaped bow leg whose leg gap is over 5cm, or X-shaped bow leg whose distance between both feet is over 3cm 3. Female patient who takes pain-relief medications at least one time in menstruation period due to pain. 4. Female patient who is not on a diet in research period. 5. Patient who can write written consent and keep on rules regarding the clinical trial.

Exclusion criteria

Exclusion criteria: 1. Patient who has cardiovascular disease or takes anticoagulants. 2. Patient who takes drugs regulary for any underlying diseases. 3. Patient who has dermatologic diseases. 4. Patient who has hematologic neoplasm. 5. Patient who is pregnant or planning for pregnancy in 6 months. 6. Patient who is getting other treatments due to low back pain. 7. Patient who had musculoskeletal surgery such as correction of genu varum or artificial hip joint replacement 8. Patient who was enrolled in other clinical trials in 4 weeks. 9. Patient who is inadequate for cilinical trial by researchers' opinion.

Design outcomes

Primary

MeasureTime frame
Decrease of leg gap;Safety(iadverse reaction, .clinical laboratory test result, vital sign)

Secondary

MeasureTime frame
Tibiofemoral angle;hip joint muslce properties;cosmetic effect;distance between knee and hip;bodyweight;abdominal circumference;height;joint space width;pain scale during menstruation

Countries

Korea, Republic of

Contacts

Public ContactSeong Hoon Park

Hallym University Medical Center-Kangnam

seigaku17@hallym.or.kr

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026